July 2008 Volume 5 Number 7
Visit Nature Clinical Practice Urology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0VfT0E1
=====================================================================
Laboratory Investigation presents: Understanding the development of
human bladder cancer by using a whole-organ genomic mapping strategy
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BvKH0Ez
Can this disease be detected earlier? Genome-wide mapping of human
bladder cancer has identified key genetic risk areas for cancer
development and provides new insight into early genetic origins of
cancer. View the complete article online at Laboratory Investigation:
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BvKH0Ez
=====================================================================
----------------------
EDITORIAL
----------------------
Plagiarism: cutting out cut-and-paste jobs
Nayanah Siva
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIe0EW
----------------------
RESEARCH HIGHLIGHTS
----------------------
Optimum management of emphysematous pyelonephritis: a systematic review
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIf0EX
The poppy-seed test is a cheap and accurate diagnostic tool for
colovesical fistula
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIg0EY
DNA hypomethylation increases the risk of bladder cancer
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIh0EZ
Restoration of the penis after accidental amputation during circumcision
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIi0Ea
Factors that influence patients' participation in prostate cancer trials
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIj0Eb
Adding antifibrinolytics to BCG instillations might enhance their
antitumor efficacy
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIk0Ec
Does routine PSA testing decrease prostate cancer mortality?
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIl0Ed
IMP3 is a promising biomarker in urological cancers
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIm0Ee
Laparoscopic surgery: a safe option even for vulnerable patients
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIn0Ef
----------------------
PRACTICE POINTS
----------------------
Is the Phoenix definition superior to ASTRO for predicting clinical
outcomes in prostate cancer?
Andrew J Stephenson
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIo0Eg
Should holmium laser enucleation be the new gold standard for bladder
outlet obstruction caused by BPH?
Gerasimos Alivizatos and Andreas Skolarikos
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIp0Eh
What is the clinical significance of ipsilateral renal lesions during
nephron-sparing surgery?
Paul L Crispen and Bradley C Leibovich
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIq0Ei
Nomogram for predicting survival in men with clinically localized prostate
cancer who do not undergo definitive therapy
Laurence Klotz
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIr0Ej
Is Mohs micrographic surgery a safe and effective treatment option in
patients with penile carcinoma?
Alberto R Casabe and Esteban N Casabe
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIs0Ek
----------------------
VIEWPOINT
----------------------
Do we need more nomograms for predicting outcomes in patients with
prostate cancer?
Michael W Kattan
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIt0El
----------------------
REVIEWS
----------------------
Bladder-sparing therapy for muscle-infiltrating bladder cancer
Vito Pansadoro and Paolo Emiliozzi
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIu0Em
Statins and prostate cancer prevention: where we are now, and future
directions
Teemu J Murtola, Tapio Visakorpi, Jorma Lahtela, Heimo Syvala and
Teuvo LJ Tammela
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIv0En
Testosterone deficiency: a common, unrecognized syndrome
Jacques L Tostain and Francois Blanc
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIw0Eo
----------------------
CASE STUDIES
----------------------
A case of synchronous bilateral testicular seminoma
Matthew J Resnick, Daniel Canter, Benjamin M Brucker, Alexander Kutikov,
Thomas J Guzzo and Alan J Wein
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIx0Ep
A case of relapsing secondary bladder adenocarcinoma after right colonic
cancer
Luciano Izzo, Dario Pietrasanta, Paolo Izzo, Maria Caputo,
Pierfrancesco Di Cello, Paolo Meloni and Antonio Bolognese
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BzIy0Eq
=====================================================================
Nature Publishing Group and Sermo have partnered to help US physicians
access, interpret, and contribute to current medical research.
In this collaboration, NPG has added 'Discuss on Sermo' links to the
online versions of articles in 12 of its leading medical journals,
including Nature Clinical Practice Urology. These links will allow US
physicians reading the journals to create or join discussions of the
articles in Sermo's physician-only knowledge-sharing community.
Find out more at http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0BqbP0ER
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/el7o0Xztnp0HjO0Zzu0Ex
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
